Table 1.

Clinicopathological features of 80 high-grade serous ovarian carcinomas

Patient characteristics		All patients (n).	HR-deficient (n). (%)	HR-proficient (n). (%)	P value
						80	34	46
		Age	≥55	52		17 (50)	35 (76)	0.0192
<55	28		17 (50)	11 (24)
Stage	I	3	0 (0)	3 (7)	0.165
	II	7	2 (6)	5 (11)
	III	50	20 (59)	30 (65)
	IV	20	12 (35)	8 (17)
Residual tumor	Yes	63	27 (79)	36 (78)	1
	No	17	7 (21)	10 (22)
Platinum-sensitivity*	Sensitive	30	19 (60)	11 (31)	0.0039
	Partial sensitive	16	8 (25)	8 (22)
	Resistant	19	3 (9)	16 (44)

*The patients who refused or dropped out of chemotherapy (n=3) and who had no disease progression (n=12) were excluded.

†Significant values are underlined.

HR, homologous recombination.